Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.42 Trillion Total Companies: 1,736
Total Market Cap (USD)
$1.42 Trillion
Companies Listed
1,736
Largest Company
Brii Biosciences Limited
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 601 |
Brii Biosciences Limited
PINK:BRIBF |
$135.65 Million | $135.65 Million | USA | $0.30 | +0.00% | +0.73% | 165.02K |
| 602 |
NervGen Pharma Corp
OTCQB:NGENF |
$135.47 Million | $135.47 Million | USA | $2.07 | -4.17% | +11.89% | 1.01 Million |
| 603 |
Open Orphan plc
PINK:OPORF |
$135.41 Million | $135.41 Million | USA | $0.24 | +0.00% | +0.00% | 0.00 |
| 604 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$134.57 Million | $134.57 Million | USA | $7.47 | -3.74% | -5.32% | 3.17 Million |
| 605 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
$134.28 Million | $134.28 Million | USA | $4.47 | +0.00% | +0.22% | 47.39 Million |
| 606 |
Biosolution Co.Ltd
KQ:086820 |
$133.82 Million | ₩195.94 Billion | Korea | ₩12460.00 | +3.66% | +6.86% | 10.14 Million |
| 607 |
Milestone Pharmaceuticals Inc
NASDAQ:MIST |
$130.95 Million | $130.95 Million | USA | $1.70 | -4.49% | -4.49% | 32.49 Million |
| 608 |
Theratechnologies Inc.
NASDAQ:THTX |
$129.60 Million | $129.60 Million | USA | $3.39 | +0.00% | +2.73% | 16.16 Million |
| 609 |
Sinphar Pharmaceutical Co Ltd
TW:1734 |
$129.07 Million | NT$4.27 Billion | Taiwan | NT$31.05 | -0.48% | +1.47% | 6.25 Million |
| 610 |
Galectin Therapeutics Inc
NASDAQ:GALT |
$129.01 Million | $129.01 Million | USA | $2.82 | -10.48% | -7.84% | 7.93 Million |
| 611 |
Genome & Company
KQ:314130 |
$128.83 Million | ₩188.64 Billion | Korea | ₩8750.00 | +1.63% | +25.54% | 14.95 Million |
| 612 |
Shanghai Rightongene Biotechnology Co. Ltd. A
SHG:688217 |
$128.25 Million | CN¥941.02 Million | China | CN¥29.84 | +0.13% | +4.78% | 16.71 Million |
| 613 |
Karyopharm Therapeutics Inc
NASDAQ:KPTI |
$127.11 Million | $127.11 Million | USA | $8.40 | +0.24% | +2.07% | 18.81 Million |
| 614 |
Hansa Biopharma AB
ST:HNSA |
$127.01 Million | Skr1.42 Billion | Sweden | Skr30.06 | -1.96% | -0.86% | 8.78 Million |
| 615 |
Bioversys AG
SW:BIOV |
$126.24 Million | CHF115.60 Million | Switzerland | CHF27.00 | -2.88% | +15.88% | 69.38K |
| 616 |
Acepodia, Inc.
TWO:6976 |
$126.22 Million | NT$4.18 Billion | Taiwan | NT$12.25 | -1.21% | -4.67% | 14.78 Million |
| 617 |
Nkarta Inc
NASDAQ:NKTX |
$126.13 Million | $126.13 Million | USA | $2.24 | -3.45% | -12.84% | 16.70 Million |
| 618 |
Nautilus Biotechnology Inc
NASDAQ:NAUT |
$126.04 Million | $126.04 Million | USA | $2.74 | +3.40% | +12.76% | 5.23 Million |
| 619 |
Context Therapeutics Inc
NASDAQ:CNTX |
$124.73 Million | $124.73 Million | USA | $2.92 | +2.10% | +0.00% | 22.97 Million |
| 620 |
Zura Bio Limited
F:94E |
$124.64 Million | €121.42 Million | Germany | €5.55 | +2.78% | -5.93% | 65.10K |
| 621 |
Panion & BF Biotech Inc
TW:1760 |
$123.88 Million | NT$4.10 Billion | Taiwan | NT$61.50 | +1.32% | +3.54% | 3.71 Million |
| 622 |
AC Immune Ltd
NASDAQ:ACIU |
$123.82 Million | $123.82 Million | USA | $3.09 | -6.93% | +1.64% | 7.36 Million |
| 623 |
Mediwound Ltd
NASDAQ:MDWD |
$123.00 Million | $123.00 Million | USA | $17.00 | -2.30% | -2.13% | 1.64 Million |
| 624 |
Autolus Therapeutics Ltd
NASDAQ:AUTL |
$122.29 Million | $122.29 Million | USA | $1.45 | -3.97% | -9.38% | 36.56 Million |
| 625 |
Jacobio Pharmaceuticals Group Co. Ltd.
PINK:JBPHF |
$122.14 Million | $122.14 Million | USA | $0.30 | +0.00% | +0.00% | 0.00 |
| 626 |
PROTALIX BIOTHERAP.DL-01
F:PBDA |
$120.92 Million | €117.80 Million | Germany | €1.92 | -19.33% | -21.31% | 17.53K |
| 627 |
Atrys Health SL
MC:ATRY |
$120.86 Million | €117.74 Million | Spain | €2.82 | -2.76% | -3.09% | 1.15 Million |
| 628 |
Gongwin Biopharm Holdings Co. Ltd.
TWO:6617 |
$120.83 Million | NT$4.00 Billion | Taiwan | NT$73.70 | -6.83% | -7.87% | 5.76 Million |
| 629 |
Zhaoke Ophthalmology Limited
F:9FX |
$120.81 Million | €117.69 Million | Germany | €0.34 | +1.81% | -3.98% | 14.25K |
| 630 |
Cardiff Oncology Inc
NASDAQ:CRDF |
$120.74 Million | $120.74 Million | USA | $1.81 | -5.73% | -9.05% | 17.05 Million |
| 631 |
Recce Pharmaceuticals Ltd
PINK:RECEF |
$120.60 Million | $120.60 Million | USA | $0.60 | +0.00% | +0.00% | 0.00 |
| 632 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
$120.14 Million | $120.14 Million | USA | $8.22 | -5.63% | -14.82% | 1.26 Million |
| 633 |
Inozyme Pharma Inc
NASDAQ:INZY |
$119.94 Million | $119.94 Million | USA | $4.00 | +0.00% | +0.25% | 26.50 Million |
| 634 |
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL |
$119.23 Million | $119.23 Million | USA | $2.52 | -7.88% | -17.81% | 16.14 Million |
| 635 |
Sangamo Therapeutics Inc
NASDAQ:SGMO |
$118.74 Million | $118.74 Million | USA | $0.36 | -5.26% | -13.02% | 111.93 Million |
| 636 |
Dimerix Ltd
PINK:SBMJF |
$117.63 Million | $117.63 Million | USA | $0.25 | +0.00% | +0.00% | 0.00 |
| 637 |
Healios K.K
PINK:HLOSF |
$116.20 Million | $116.20 Million | USA | $1.94 | +0.00% | +0.00% | 0.00 |
| 638 |
Mycenax Biotech
TWO:4726 |
$115.74 Million | NT$3.83 Billion | Taiwan | NT$32.80 | +3.47% | +0.46% | 6.78 Million |
| 639 |
ATRYS HEALTH S.A. EO-01
F:A2T |
$115.28 Million | €112.31 Million | Germany | €2.69 | -1.10% | -8.81% | 109.64K |
| 640 |
OCUPHIRE PHARMA DL-0001
F:R3X1 |
$115.10 Million | €112.14 Million | Germany | €4.05 | -1.82% | -0.61% | 38.47K |
| 641 |
AC IMMUNE SA SF-02
F:IMR |
$114.95 Million | €111.98 Million | Germany | €2.80 | +5.67% | +17.19% | 28.67K |
| 642 |
MacroGenics Inc
NASDAQ:MGNX |
$113.87 Million | $113.87 Million | USA | $2.98 | -3.25% | -13.12% | 34.25 Million |
| 643 |
Century Therapeutics Inc
NASDAQ:IPSC |
$112.92 Million | $112.92 Million | USA | $2.30 | +0.44% | -16.97% | 26.37 Million |
| 644 |
Codexis Inc
NASDAQ:CDXS |
$112.91 Million | $112.91 Million | USA | $1.47 | +0.00% | +18.55% | 93.22 Million |
| 645 |
Unicycive Therapeutics Inc
NASDAQ:UNCY |
$112.65 Million | $112.65 Million | USA | $6.76 | -3.15% | -2.73% | 10.92 Million |
| 646 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$112.35 Million | $112.35 Million | USA | $2.46 | -4.65% | +0.41% | 6.70 Million |
| 647 |
ARMATA PHARMACEUT.
F:TG1N |
$112.09 Million | €109.20 Million | Germany | €9.95 | +9.94% | +0.51% | 27.30K |
| 648 |
Agenus Inc
NASDAQ:AGEN |
$112.04 Million | $112.04 Million | USA | $3.76 | -5.76% | +11.57% | 11.92 Million |
| 649 |
7754
TWO:7754 |
$111.88 Million | NT$3.70 Billion | Taiwan | NT$64.00 | +6.31% | +13.27% | 9.31 Million |
| 650 |
Heron Therapeuti
NASDAQ:HRTX |
$110.91 Million | $110.91 Million | USA | $0.84 | -3.04% | -15.00% | 48.68 Million |
| 651 |
ProQR Therapeutics BV
NASDAQ:PRQR |
$110.70 Million | $110.70 Million | USA | $1.72 | -2.82% | -4.44% | 7.75 Million |
| 652 |
Corbus Pharmaceuticals Holding
NASDAQ:CRBP |
$110.25 Million | $110.25 Million | USA | $9.05 | -6.02% | -9.86% | 4.92 Million |
| 653 |
Genexine Inc
KQ:095700 |
$110.21 Million | ₩161.37 Billion | Korea | ₩4765.00 | -1.04% | -3.15% | 11.88 Million |
| 654 |
Tanvex BioPharma Inc
TW:6541 |
$109.75 Million | NT$3.63 Billion | Taiwan | NT$43.35 | +2.97% | +2.60% | 13.27 Million |
| 655 |
Botanix Pharmaceuticals Limited
PINK:BXPHF |
$109.73 Million | $109.73 Million | USA | $0.25 | +0.00% | +0.00% | 93.00K |
| 656 |
Dishman Carbogen Amcis Limited
NSE:DCAL |
$108.92 Million | ₹9.43 Billion | India | ₹171.66 | +4.97% | +4.35% | 9.28 Million |
| 657 |
OBI Pharma
TWO:4174 |
$108.50 Million | NT$3.59 Billion | Taiwan | NT$39.65 | +1.54% | -0.38% | 13.23 Million |
| 658 |
Jiangsu Cowin Biotech Co. Ltd. A
SHG:688426 |
$108.49 Million | CN¥796.05 Million | China | CN¥22.77 | -0.04% | +0.62% | 26.05 Million |
| 659 |
Onward Medical N.V.
BR:ONWD |
$107.20 Million | €104.43 Million | Belgium | €3.63 | -2.68% | -8.10% | 2.44 Million |
| 660 |
Fate Therapeutics Inc
NASDAQ:FATE |
$106.85 Million | $106.85 Million | USA | $1.06 | -6.19% | -17.83% | 37.37 Million |
| 661 |
Canton Strategic Holdings, Inc.
NASDAQ:CNTN |
$106.30 Million | $106.30 Million | USA | $3.51 | -11.27% | -24.79% | 12.34 Million |
| 662 |
vTv Therapeutics Inc
NASDAQ:VTVT |
$105.36 Million | $105.36 Million | USA | $36.30 | -1.09% | +3.66% | 1.34 Million |
| 663 |
Cibus Global LLC
NASDAQ:CBUS |
$104.57 Million | $104.57 Million | USA | $2.77 | -24.73% | -30.23% | 13.59 Million |
| 664 |
TiumBio Co. Ltd
KQ:321550 |
$104.49 Million | ₩153.00 Billion | Korea | ₩8680.00 | +11.28% | +21.91% | 8.99 Million |
| 665 |
Oramed Pharmaceuticals Inc
NASDAQ:ORMP |
$104.09 Million | $104.09 Million | USA | $3.57 | -1.11% | +7.21% | 3.52 Million |
| 666 |
Mersana Therapeutics Inc
NASDAQ:MRSN |
$102.67 Million | $102.67 Million | USA | $29.08 | +0.14% | -0.07% | 2.50 Million |
| 667 |
Acumen Pharmaceuticals Inc
NASDAQ:ABOS |
$102.67 Million | $102.67 Million | USA | $2.92 | -5.50% | -13.10% | 17.06 Million |
| 668 |
25K0
F:25K0 |
$102.39 Million | €99.75 Million | Germany | €6.80 | -0.73% | -3.55% | 772.00 |
| 669 |
Egetis Therapeutics AB (publ)
ST:EGTX |
$102.21 Million | Skr1.15 Billion | Sweden | Skr5.45 | +0.55% | +2.06% | 17.69 Million |
| 670 |
Tenaya Therapeutics Inc
NASDAQ:TNYA |
$102.04 Million | $102.04 Million | USA | $0.82 | -4.07% | -8.10% | 134.02 Million |
| 671 |
Vaxcell-Bio Therapeutics Co. Ltd
KQ:323990 |
$101.73 Million | ₩148.95 Billion | Korea | ₩8170.00 | -1.45% | +0.00% | 5.28 Million |
| 672 |
Neurogene Inc
NASDAQ:NGNE |
$101.60 Million | $101.60 Million | USA | $19.50 | -7.50% | -15.47% | 4.69 Million |
| 673 |
Tharimmune Inc.
NASDAQ:THAR |
$101.29 Million | $101.29 Million | USA | $3.51 | -11.27% | -21.76% | 15.48 Million |
| 674 |
Ovid Therapeutics Inc
NASDAQ:OVID |
$101.12 Million | $101.12 Million | USA | $2.30 | +14.43% | +7.98% | 78.11 Million |
| 675 |
Biomm S.A
SA:BIOM3 |
$100.83 Million | R$614.04 Million | Brazil | R$6.95 | -2.80% | -3.47% | 1.61 Million |
| 676 |
Ryvu Therapeutics SA
WAR:RVU |
$100.75 Million | zł418.94 Million | Poland | zł23.35 | +0.21% | -7.71% | 492.67K |
| 677 |
Medigen Biotechnology
TWO:3176 |
$100.57 Million | NT$3.33 Billion | Taiwan | NT$32.75 | +11.02% | +8.62% | 6.40 Million |
| 678 |
PROQR THERAPEUTICS EO-04
F:0PQ |
$100.44 Million | €97.85 Million | Germany | €1.50 | +0.67% | -0.99% | 41.27K |
| 679 |
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898 |
$100.07 Million | CN¥734.22 Million | China | CN¥11.75 | +0.34% | +2.62% | 33.01 Million |
| 680 |
ONWARD MEDICAL BV EO -12
F:63E |
$99.94 Million | €97.37 Million | Germany | €3.60 | -1.10% | -10.12% | 14.75K |
| 681 |
Black Diamond Therapeutics Inc
NASDAQ:BDTX |
$99.70 Million | $99.70 Million | USA | $2.17 | -2.69% | -4.41% | 14.38 Million |
| 682 |
Orthocell Ltd
AU:OCC |
$99.69 Million | AU$161.00 Million | Australia | AU$0.78 | +0.00% | -6.02% | 7.65 Million |
| 683 |
Oncolytics Biotech Inc
NASDAQ:ONCY |
$99.64 Million | $99.64 Million | USA | $0.96 | -3.06% | -5.83% | 30.47 Million |
| 684 |
Energenesis Biomedical Co. Ltd.
TW:6657 |
$98.30 Million | NT$3.25 Billion | Taiwan | NT$47.65 | -0.63% | +1.17% | 12.54 Million |
| 685 |
RYVU THERAPEUTICS ZY-40
F:9Y4 |
$98.16 Million | €95.63 Million | Germany | €5.33 | -2.20% | -8.42% | 5.42K |
| 686 |
CONTEXT THERAPEUT.DL-001
F:6K9 |
$98.04 Million | €95.51 Million | Germany | €2.40 | -6.98% | -0.83% | 22.11K |
| 687 |
VitaSpring Biomedical Co. Ltd
PINK:VSBC |
$97.73 Million | $97.73 Million | USA | $1.00 | +0.00% | +0.00% | 0.00 |
| 688 |
Paradigm Biopharmaceuticals Limited
PINK:PBIGF |
$97.36 Million | $97.36 Million | USA | $0.38 | +0.00% | +0.00% | 0.00 |
| 689 |
Armata Pharmaceuticals Inc
NYSE MKT:ARMP |
$94.18 Million | $94.18 Million | USA | $8.54 | -11.13% | -28.60% | 1.04 Million |
| 690 |
Vor Biopharma Inc
NASDAQ:VOR |
$93.77 Million | $93.77 Million | USA | $13.00 | -5.25% | -18.75% | 14.98 Million |
| 691 |
Pharmosa Biopharm Inc.
TWO:6875 |
$93.15 Million | NT$3.08 Billion | Taiwan | NT$40.10 | -0.62% | -0.99% | 3.64 Million |
| 692 |
VAXART INC. DL-10
F:NB11 |
$92.50 Million | €90.12 Million | Germany | €0.38 | +0.00% | +9.32% | 224.36K |
| 693 |
Jiangsu GDK Biotechnology Co Ltd
SHG:688670 |
$92.38 Million | CN¥677.81 Million | China | CN¥18.58 | -0.43% | +0.98% | 46.05 Million |
| 694 |
Gossamer Bio Inc
NASDAQ:GOSS |
$90.26 Million | $90.26 Million | USA | $0.43 | -7.99% | -14.40% | 398.08 Million |
| 695 |
Cognition Therapeutics Inc
NASDAQ:CGTX |
$89.95 Million | $89.95 Million | USA | $1.10 | -4.35% | -1.79% | 15.22 Million |
| 696 |
Inovio Pharmaceuticals Inc
NASDAQ:INO |
$88.56 Million | $88.56 Million | USA | $1.66 | -1.19% | -4.05% | 18.51 Million |
| 697 |
Atossa Therapeutics Inc
F:YAG2 |
$88.44 Million | €86.16 Million | Germany | €6.75 | +0.00% | +1120.61% | 173.00K |
| 698 |
MedPacto Inc
KQ:235980 |
$88.17 Million | ₩129.09 Billion | Korea | ₩5820.00 | +8.58% | +17.22% | 11.62 Million |
| 699 |
BRIM Biotechnology Inc.
TWO:6885 |
$87.55 Million | NT$2.90 Billion | Taiwan | NT$29.85 | +0.00% | +0.00% | 248.10K |
| 700 |
Anixa Biosciences Inc
NASDAQ:ANIX |
$87.46 Million | $87.46 Million | USA | $2.77 | -4.15% | -7.05% | 2.36 Million |
| 701 |
Immunoprecise Antibodies Ltd
NASDAQ:IPA |
$86.83 Million | $86.83 Million | USA | $2.07 | +7.25% | -25.00% | 41.05 Million |
| 702 |
GENOVIS AB SE-40
F:5GV |
$85.12 Million | €82.93 Million | Germany | €1.47 | -0.81% | -3.04% | 5.00K |
| 703 |
Tiziana Life Sciences Ltd
NASDAQ:TLSA |
$84.73 Million | $84.73 Million | USA | $1.26 | -3.08% | -8.03% | 2.59 Million |
| 704 |
180 Life Sciences Corp
NASDAQ:ATNF |
$84.68 Million | $84.68 Million | USA | $16.80 | +905.99% | +667.12% | 244.08 Million |
| 705 |
iNtRON Biotechnology Inc
KQ:048530 |
$83.99 Million | ₩122.98 Billion | Korea | ₩4870.00 | +3.84% | -0.20% | 68.50 Million |
| 706 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
$83.95 Million | $83.95 Million | USA | $5.38 | +0.00% | +0.00% | 4.38 Million |
| 707 |
Hillevax Inc
NASDAQ:HLVX |
$83.07 Million | $83.07 Million | USA | $2.09 | +0.00% | -0.48% | 19.87 Million |
| 708 |
Adocia
PA:ADOC |
$82.69 Million | €80.56 Million | France | €5.70 | -2.23% | -11.76% | 5.11 Million |
| 709 |
Cassava Sciences Inc
NASDAQ:SAVA |
$82.54 Million | $82.54 Million | USA | $1.91 | -4.50% | -5.91% | 17.40 Million |
| 710 |
Genovis AB (publ.)
ST:GENO |
$81.38 Million | Skr912.88 Million | Sweden | Skr16.16 | -0.25% | -3.12% | 1.94 Million |
| 711 |
Coya Therapeutics, Inc. Common Stock
NASDAQ:COYA |
$81.32 Million | $81.32 Million | USA | $4.45 | +1.14% | -9.18% | 2.70 Million |
| 712 |
Eliem Therapeutics Inc
NASDAQ:ELYM |
$81.07 Million | $81.07 Million | USA | $3.09 | +0.00% | +0.00% | 105.39K |
| 713 |
Shenzhen CAU Technology Co Ltd
SHE:000004 |
$80.66 Million | CN¥591.85 Million | China | CN¥6.16 | +4.94% | +9.61% | 165.34 Million |
| 714 |
Genelux Corporation Common Stock
NASDAQ:GNLX |
$79.36 Million | $79.36 Million | USA | $2.59 | -1.15% | -7.50% | 3.43 Million |
| 715 |
Sutro Biopharma
NASDAQ:STRO |
$79.09 Million | $79.09 Million | USA | $21.79 | -5.01% | -14.33% | 3.38 Million |
| 716 |
Tenax Therapeutics Inc
NASDAQ:TENX |
$78.98 Million | $78.98 Million | USA | $15.57 | +2.60% | +7.27% | 8.69 Million |
| 717 |
Alpha Cognition Inc
NASDAQ:ACOG |
$78.97 Million | $78.97 Million | USA | $5.75 | -0.17% | -2.38% | 1.64 Million |
| 718 |
aTyr Pharma, Inc.
NASDAQ:ATYR |
$77.91 Million | $77.91 Million | USA | $0.82 | -7.54% | -12.91% | 32.90 Million |
| 719 |
Synergy Innovation Co. Ltd
KQ:048870 |
$77.78 Million | ₩113.88 Billion | Korea | ₩2030.00 | -3.10% | -1.46% | 8.67 Million |
| 720 |
Adverum Biotechnologies Inc
NASDAQ:ADVM |
$77.42 Million | $77.42 Million | USA | $4.36 | +0.00% | +3.81% | 11.22 Million |
| 721 |
Kintor Pharmaceutical Limited
PINK:KNTPF |
$77.25 Million | $77.25 Million | USA | $0.21 | +0.00% | +36.54% | 2.06K |
| 722 |
Kangstem Biotech Co. Ltd
KQ:217730 |
$77.24 Million | ₩113.09 Billion | Korea | ₩2665.00 | +3.90% | +17.92% | 24.63 Million |
| 723 |
Genovate Biotechnology Co Ltd
TWO:4130 |
$77.18 Million | NT$2.55 Billion | Taiwan | NT$32.40 | +0.62% | -7.30% | 41.59 Million |
| 724 |
Biomea Fusion Inc
NASDAQ:BMEA |
$77.04 Million | $77.04 Million | USA | $1.17 | -4.10% | -20.41% | 21.89 Million |
| 725 |
IGM Biosciences Inc
NASDAQ:IGMS |
$76.57 Million | $76.57 Million | USA | $1.27 | -2.31% | -0.78% | 12.53 Million |
| 726 |
Cantargia AB
ST:CANTA |
$76.57 Million | Skr858.95 Million | Sweden | Skr3.96 | +1.80% | -3.53% | 44.69 Million |
| 727 |
Bioventix PLC
F:51B |
$75.82 Million | €73.87 Million | Germany | €17.80 | +11.95% | +6.59% | 1.26K |
| 728 |
Satellos Bioscience Inc
OTCQB:MSCLF |
$75.67 Million | $75.67 Million | USA | $0.48 | -7.12% | -12.18% | 531.90K |
| 729 |
Arcticzymes Technologies ASA
OL:AZT |
$75.20 Million | Nkr856.80 Million | Norway | Nkr20.10 | -1.47% | -7.37% | 900.35K |
| 730 |
AN2 Therapeutics Inc
NASDAQ:ANTX |
$74.59 Million | $74.59 Million | USA | $4.62 | -7.60% | -15.38% | 77.37 Million |
| 731 |
Fortress Biotech Inc
NASDAQ:FBIO |
$74.11 Million | $74.11 Million | USA | $3.16 | +1.28% | -5.95% | 26.16 Million |
| 732 |
Rani Therapeutics Holdings Inc
NASDAQ:RANI |
$73.96 Million | $73.96 Million | USA | $1.19 | -9.16% | -10.53% | 20.37 Million |
| 733 |
Molecular Partners AG
PINK:MLLCF |
$73.81 Million | $73.81 Million | USA | $4.22 | +0.00% | +0.00% | 0.00 |
| 734 |
Scancell Holdings plc
PINK:SCNLF |
$73.42 Million | $73.42 Million | USA | $0.13 | +0.00% | +0.00% | 0.00 |
| 735 |
Abion Inc.
KQ:203400 |
$73.18 Million | ₩107.16 Billion | Korea | ₩2885.00 | -2.53% | +6.85% | 29.10 Million |
| 736 |
Whitehawk Therapeutics, Inc.
NASDAQ:WHWK |
$72.28 Million | $72.28 Million | USA | $3.81 | -3.54% | -5.46% | 4.08 Million |
| 737 |
Precision BioSciences Inc
NASDAQ:DTIL |
$71.52 Million | $71.52 Million | USA | $7.03 | +1.44% | +31.40% | 6.85 Million |
| 738 |
Bioceltix S.A.
WAR:BCX |
$71.31 Million | zł296.51 Million | Poland | zł77.40 | +0.00% | -2.03% | 80.06K |
| 739 |
Abionyx Pharma SA
PA:ABNX |
$70.83 Million | €69.00 Million | France | €3.29 | -2.08% | -4.50% | 2.74 Million |
| 740 |
SAB Biotherapeutics Inc
NASDAQ:SABS |
$70.73 Million | $70.73 Million | USA | $3.70 | -9.09% | -9.76% | 16.26 Million |
| 741 |
Xlife Sciences AG
SW:XLS |
$70.64 Million | CHF64.69 Million | Switzerland | CHF22.40 | +0.45% | +1.36% | 50.53K |
| 742 |
Geninus Inc.
KQ:389030 |
$70.04 Million | ₩102.56 Billion | Korea | ₩6050.00 | +6.14% | +21.61% | 27.77 Million |
| 743 |
Seer Inc
NASDAQ:SEER |
$69.52 Million | $69.52 Million | USA | $1.74 | -2.25% | -1.69% | 9.32 Million |
| 744 |
Captor Therapeutics S.A.
WAR:CTX |
$68.89 Million | zł286.47 Million | Poland | zł79.80 | -1.48% | -8.90% | 196.24K |
| 745 |
Pmv Pharmaceuticals Inc
NASDAQ:PMVP |
$68.89 Million | $68.89 Million | USA | $1.49 | -4.49% | -8.02% | 24.85 Million |
| 746 |
Formosa Pharmaceuticals, Inc.
TW:6838 |
$68.49 Million | NT$2.27 Billion | Taiwan | NT$26.55 | +4.12% | +3.71% | 5.32 Million |
| 747 |
XSpray Pharma AB
ST:XSPRAY |
$68.36 Million | Skr766.86 Million | Sweden | Skr25.00 | -0.60% | +2.25% | 715.11K |
| 748 |
Gain Therapeutics Inc
NASDAQ:GANX |
$67.94 Million | $67.94 Million | USA | $1.95 | -25.57% | -31.10% | 20.65 Million |
| 749 |
IMMUNOPRECISE ANTIBOD.
F:TQB |
$67.83 Million | €66.08 Million | Germany | €1.58 | -4.52% | -26.38% | 39.02K |
| 750 |
BIOINVENT INTERN. SK 2
F:BIX0 |
$67.59 Million | €65.84 Million | Germany | €2.14 | +7.39% | +4.91% | 12.19K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries